Dr. Asimakopoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Drive
Moores Cancer Center 2308
La Jolla, CA 92093Phone+1 858-246-5223
Summary
- Dr. Fotios Asimakopoulos is an oncologist in La Jolla, CA. He received his medical degree from School of Clinical Medicine, University of Cambridge and has been in practice 21 years. He specializes in hematologic oncology and is experienced in immunotherapy, hematologic oncology, bone marrow transplantation, multiple myeloma, and vaccine-based tumor therapy.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2009
- Brigham and Women's HospitalResidency, Internal Medicine, 1999 - 2001
- Hebrew University of JerusalemGolda Meir Fellow, Hematology, 1997 - 1999
- School of Clinical Medicine, University of CambridgeClass of 1996
- University of BristolBSc, Cellular and Molecular Pathology, First Class Honours, 1988 - 1991
Certifications & Licensure
- CA State Medical License 2011 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member American Society for Clinical Investigation, 2023
Publications & Presentations
PubMed
- 103 citationsTumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.Muhammad Umair Mushtaq, Athanasios Papadas, Adam Pagenkopf, Evan Flietner, Zachary Morrow
Journal for Immunotherapy of Cancer. 2018-07-03 - 99 citationsMacrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cellsJaehyup Kim, Ryan A. Denu, Bridget A. Dollar, Leah E. Escalante, Justin P. Kuether
British Journal of Haematology. 2012-08-01 - 110 citationsAutologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis.Binod Dhakal, Aniko Szabo, Saurabh Chhabra, Mehdi Hamadani, Anita D'Souza
JAMA Oncology. 2018-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: